NanoViricides, Inc.
NNVC · AMEX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $5,549 | $5,437 | $6,392 | $5,785 |
| G&A Expenses | $4,043 | $3,079 | $2,551 | $2,329 |
| SG&A Expenses | $4,043 | $3,079 | $2,551 | $2,329 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,592 | $8,516 | $8,943 | $8,114 |
| Operating Income | -$9,592 | -$8,516 | -$8,943 | -$8,114 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $125 | $222 | $355 | $7 |
| Pre-Tax Income | -$9,467 | -$8,294 | -$8,589 | -$8,107 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9,467 | -$8,294 | -$8,589 | -$8,107 |
| % Margin | – | – | – | – |
| EPS | -0.63 | -0.7 | -0.74 | -0.7 |
| % Growth | 10% | 5.4% | -5.7% | – |
| EPS Diluted | -0.63 | -0.7 | -0.74 | -0.7 |
| Weighted Avg Shares Out | 15,117 | 11,871 | 11,626 | 11,535 |
| Weighted Avg Shares Out Dil | 15,117 | 11,871 | 11,626 | 11,535 |
| Supplemental Information | – | – | – | – |
| Interest Income | $125 | $272 | $356 | $12 |
| Interest Expense | $0 | $50 | $1 | $5 |
| Depreciation & Amortization | $744 | $759 | $748 | $723 |
| EBITDA | -$8,723 | -$7,485 | -$7,840 | -$7,378 |
| % Margin | – | – | – | – |